Results 231 to 240 of about 216,694 (240)

Relapses and Progression of Disability in Multiple Sclerosis

New England Journal of Medicine, 2000
Sandra Vukusic, T Moreau, C Confavreux   +2 more
exaly  

Vaccinations and the Risk of Relapse in Multiple Sclerosis

New England Journal of Medicine, 2001
Sandra Vukusic, Samy Suissa, C Confavreux   +2 more
exaly  

Altered human oligodendrocyte heterogeneity in multiple sclerosis

Nature, 2019
David Van Bruggen, Eneritz Agirre, Charles Ffrench-Constant   +2 more
exaly  

Hepatitis B Vaccination and the Risk of Multiple Sclerosis

New England Journal of Medicine, 2001
Kimberly Brodovicz, , Alberto Ascherio
exaly  

Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis

Neurology, 2017
S. Rossi, V. Studer, C. Motta, S. Polidoro, Jacopo Perugini, G. Macchiarulo, A. Giovannetti, Lorena Pareja-Gutierrez, A. Calò, Isabella Colonna, R. Furlan, G. Martino, D. Centonze   +12 more
semanticscholar   +1 more source

Intramuscular Interferon Beta-1A Therapy Initiated during a First Demyelinating Event in Multiple Sclerosis

New England Journal of Medicine, 2000
Roy Beck, L D Jacobs, Alfred Sandrock
exaly  

A Population-Based Study of Multiple Sclerosis in Twins

New England Journal of Medicine, 1986
Dennis E Bulman, George Ebers, A D Sadovnick   +2 more
exaly  

Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study

New England Journal of Medicine, 2007
John D Rioux, Stephen Sawcer, Bruce Cree   +2 more
exaly  

Natalizumab for Multiple Sclerosis

New England Journal of Medicine, 2007
Richard Ransohoff, Ransohoff Richard M
exaly  

Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis

New England Journal of Medicine, 2010
Jeffrey Cohen, Xavier Montalbán, Hans-Peter Hartung   +2 more
exaly